These innovative medications , Tirzepatide , represent a remarkable advancement in treating type 2 diabetes and potentially other ailments . They all are categorized as GLP-1 pathway agonists , meaning https://anitautnl379293.thechapblog.com/40217049/retatrutide-a-deep-dive-into-metabolic-agents